Search

Author/Creator Juergens, Rosalyn A

1. Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+). (October 2021)

Authors:
Seow, Hsien; Tanuseputro, Peter; Barbera, Lisa; Earle, Craig C; Guthrie, Dawn M; Isenberg, Sarina R; Juergens, Rosalyn A; Myers, Jeffrey; Brouwers, Melissa; Tibebu, Semra; Sutradhar, Rinku
Other Names:
Morin Lucas guest-editor.; Onwuteaka-Philipsen Bregje guest-editor.
Journal:
Palliative medicine
Issue:
Volume 35:Number 9(2021)
Page Start:
1713
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial. Issue 8 (August 2020)

Authors:
Catenacci, Daniel V T; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E; Lee, Keun-Wook; Ng, Matthew C H; Enzinger, Peter C; Park, Se Hoon; Gold, Philip J; Lacy, Jill; Hochster, Howard S; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A; Kelly, Ronan J; Juergens, Rosalyn A; Kim, Jong Gwang; Bende...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 8(2020)
Page Start:
1066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Issue 1 (January 2017)

Authors:
Hellmann, Matthew D; Rizvi, Naiyer A; Goldman, Jonathan W; Gettinger, Scott N; Borghaei, Hossein; Brahmer, Julie R; Ready, Neal E; Gerber, David E; Chow, Laura Q; Juergens, Rosalyn A; Shepherd, Frances A; Laurie, Scott A; Geese, William J; Agrawal, Shruti; Young, Tina C; Li, Xuemei; Antonia, Scott J
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗